Advertisement

Pharmaceutical Chemistry Journal

, Volume 24, Issue 12, pp 869–875 | Cite as

Phosphodiesterase inhibitors as cardiotonic drugs (review)

  • I. S. Chekman
  • A. I. Grinevich
Search for New Drugs
  • 14 Downloads

Keywords

Organic Chemistry Phosphodiesterase Phosphodiesterase Inhibitor Cardiotonic Drug 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literature cited

  1. 1.
    A. I. Grinevich, N. A. Gorchakova, R. D. Samilova, et al., Scientific and Technical Advances in Pharmacology [in Russian], Tashkent (1988), pp. 96–97.Google Scholar
  2. 2.
    S. S. Liberman and Ya. N. Yakhontov, Khim.-farm. Zh., No. 9, 1046–1060 (1988).Google Scholar
  3. 3.
    I. S. Chekman, Pharmacology of Cardiotonic Drugs [in Russian], Moscow (1988).Google Scholar
  4. 4.
    I. S. Chekman and V. V. Tkachuk, Farmakol. Toksikol., No. 6, 5–15 (1984).Google Scholar
  5. 5.
    H. R. Adams, J. Thody, and J. L. Satko, Circ. Res.,51, 662–665 (1982).Google Scholar
  6. 6.
    Ahn Ho Sam, E. David, R. Watkins, and N. Priodi, Biochem. Pharmacol., No. 7, 1113–1121 (1986).Google Scholar
  7. 7.
    C. T. Alabaster, K. S. Blackburn, J. R. Joice, et al., Br. J. Pharmacol.,60, 284–285 (1977).Google Scholar
  8. 8.
    A. A. Alousi, A. E. Farach, G. Y. Lesher, and C. J. Opalka, Circ. Res.,45, 666–677 (1979).Google Scholar
  9. 9.
    K.-E. Anderson, Acta Med. Scand.,219, 65–73 (1985).Google Scholar
  10. 10.
    K. Barcenas and E. Kabela, Bol. Estud. Med. Biol.,30, 294 (1979).Google Scholar
  11. 11.
    D. S. Baim, A. V. McDowell, J. Cherniles, et al., New Engl. J. Med.,309, 748–756 (1983).Google Scholar
  12. 12.
    G. G. Belz, R. G. Alken, K. Haegele, et al., Clin. Pharm. Ther.,33, 202 (1983).Google Scholar
  13. 13.
    J. R. Benotti, W. Grossman, E. Braunwald, et al., New Engl. J. Med.,299, 1373 (1978).Google Scholar
  14. 14.
    J. A. Bristol, I. Sircar, W. H. Moos, D. B. Evans, et al., J. Med. Chem.,27, No. 9, 1099–1101 (1984).Google Scholar
  15. 15.
    S. F. Campbel, N. J. Cussans, J. C. Danilewicz, et al., 2nd SCI-RSC Med. Chem. Symp. Proc. Symp., Cambridge, 12th–14th Sept., London (1984), pp. 47–64.Google Scholar
  16. 16.
    J. Carlier and D. El Allaf, Resuscitation, Nos. 3–4, 217–231 (1984).Google Scholar
  17. 17.
    J. Dämmgen, R. Kadatz, and W. Diederen, Arzneimittel-Forsch.,31, No. 1, 151–154 (1981).Google Scholar
  18. 18.
    W. Diederen, P. Anselment, U. Mittman, et al., Cardiovasc. Pharmacother., Int. Symp., Geneva (1985), Abstr. No. 520.Google Scholar
  19. 19.
    W. Diederen and H. Weisenberg, Arzneimittel-Forsch.,31, No. la, 177–182 (1981).Google Scholar
  20. 20.
    D. El Allaf, V. D'Orio, and J. Carlier, Arch. Int. Physiol. Pharm. Biochem.,92, No. 4, 69–79 (1984).Google Scholar
  21. 21.
    M. Endoh, S. Hamashita, and N. Taira, J. Pharmacol. Exp. Ther.,221, 775–783 (1982).Google Scholar
  22. 22.
    M. Endoh, K. Satoh, and S. Yamashita, Eur. J. Pharmacol.,66, 43–52 (1980).Google Scholar
  23. 23.
    A. E. Farach, A. A. Alousi, and R. P. Schwarz, Ann. Rev. Pharmacol. Toxicol.,24, 275–328 (1984).Google Scholar
  24. 24.
    F. Follath, F. Kersting, G. R. Lewis, et al., Clin. Pharmacol. Therm.,20, 24–30 (1976).Google Scholar
  25. 25.
    C. J. Frangakis, K. P. Lasher, and A. A. Alousi, Circulation,66, 57 (1982).Google Scholar
  26. 26.
    E. Göres, P. Oehme, H. Löwe, and M. Oettel, II Berliner Wirkstoffsymposium, No. 29 (1987), pp. 5–22.Google Scholar
  27. 27.
    A. K. Heiss, Diss. Dokt. Med. Fak., Med. Tech. Univ., Munchen (1983).Google Scholar
  28. 28.
    P. Honerjäger, A. Heiss, M. Schäfer-Korting, et al., Neunin-Schmiedeberg's Arch. Pharmacol.,325, No. 3, 259–269 (1984).Google Scholar
  29. 29.
    W. S. Hillis and M. Been, Eur. Heart J.,3, Suppl. D, 97–101 (1982).Google Scholar
  30. 30.
    J. Hutton, W. S. Hillis, C. Langhan, et al., Br. J. Clin. Pharmacol.,4, 513–517 (1977).Google Scholar
  31. 31.
    D. Jewitt, K. Jennigs, and P. G. Jackson, Am. J. Med.,65, 197–202 (1978).Google Scholar
  32. 32.
    H. Landman and H. Lowe, Pharmazie,41, No. 3, 169–172 (1986).Google Scholar
  33. 33.
    E. Masao, Y. Teruyuki, T. Norio, and J. Blinks, Circulation,73, Suppl. 3, 117–133 (1986).Google Scholar
  34. 34.
    H. Masatsugu, J. Michitosi, T. Jun, et al., Jap. Circulat. J.,50, No. 7, 659–666 (1986).Google Scholar
  35. 35.
    J. P. Morgan, N. K. Lee, and J. R. Blinks, Fed. Proc.,39, 854 (1980).Google Scholar
  36. 36.
    H. Nawrath, J. Pharmacol. Exp. Ther.,218, 544–549 (1981).Google Scholar
  37. 37.
    G. Nemoz and A. F. Prigent, Ann. Pharmaceutiques France,42, No. 2, 99–112 (1984).Google Scholar
  38. 38.
    M. Petein, V. Garbera, P. Carlyle, et al., J. Am. Coll. Cardiol.,1, 675 (1983).Google Scholar
  39. 39.
    R. W. Rall, Pharmacologist,24, 277–287 (1982).Google Scholar
  40. 40.
    I. E. Rosenthal and G. R. Ferrier, J. Pharmacol. Exp. Therm.,22, 188–196 (1982).Google Scholar
  41. 41.
    N. Taira, M. Endoh, T. Tijima, et al., Arzneimitt.-Forsch.,34, No. 3a, 347–355 (1984).Google Scholar
  42. 42.
    Y. Teruyuki, J. Kuniaki, and T. Norio, J. Cardiovasc. Pharmacol.,10, 47–54 (1987).Google Scholar
  43. 43.
    I. Toshihiko and T. Norio, J. Pharmacol. Exp. Ther.,240, No. 2, 657–662 (1987).Google Scholar
  44. 44.
    W. Schmitz, Schweiz, Med. Wochenschrift,118, No. 17, 612–616 (1988).Google Scholar
  45. 45.
    H. Scholz, Cell. Calcium,5, No. 3, 282 (1984).Google Scholar
  46. 46.
    M. Shinichi, S. Shigetake, N. Yasuyuki, et al., J. Cardiovasc. Pharmacol.,8, 14–24 (1986).Google Scholar
  47. 47.
    P. D. Verduow, J. M. Hartog, L. M. Lamers, and P. R. Saxena, Cardiovasc. Pharmacother. Int. Symp. — Geneva (1985), Abstr. p. 587.Google Scholar
  48. 48.
    A. Walland, Arzneimtt.-Forsch.,35, 369–376 (1985).Google Scholar
  49. 49.
    R. E. Weishaar, S. D. Burrows, D. Loblyarz, et al., Biochem. Pharmacol.,35, No. 5, 787–790 (1986).Google Scholar
  50. 50.
    R. E. Weishaar, M. M. Quade, J. A. Sehenden, and D. B. Evans, J. Cycl. Nucl. Protein Phosphorylat. Res.,10, No. 6, 551–564 (1985).Google Scholar
  51. 51.
    B. Wetzel and N. Hauel, Ann. Rep. Med. Chem., No. 19, 71–80 (1984).Google Scholar
  52. 52.
    P. T. Wilmshurst and M. M. Webb-Peploe, Br. Heart J.,49, 447 (1983).Google Scholar
  53. 53.
    R. Young and A. Ward, Drugs,36, No. 2, 158–192 (1988).Google Scholar

Copyright information

© Plenum Publishing Corporation 1991

Authors and Affiliations

  • I. S. Chekman
    • 1
  • A. I. Grinevich
    • 1
  1. 1.A. A. Bogomolets Kiev Institute of MedicineUSSR

Personalised recommendations